---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-011892"
form_type: "8-K"
ticker: "DWTX"
cik: "0001818844"
company_name: "Dogwood Therapeutics, Inc."
filed_at: "2023-07-14T23:59:59+00:00"
generated_at: "2026-06-13T08:20:39.714625+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Virios Therapeutics enters $6.7M at-the-market equity offering with JonesTrading

## Summary
- Agreement allows sale of up to $6.7M of common stock via ATM offering under Rule 415.
- Agent JonesTrading receives 3% commission on gross sales; no obligation to sell shares.
- Offered under existing shelf registration statement S-3 (No. 333-263700), effective since April 2022.
- Agreement effective July 14, 2023; may be terminated by either party at any time.

## SEC filing metadata
- accession: 0001558370-23-011892
- form_type: 8-K
- ticker: DWTX
- cik: 0001818844
- company_name: Dogwood Therapeutics, Inc.
- filed_at: 2023-07-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818844/000155837023011892/0001558370-23-011892-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818844/000155837023011892/tmb-20230714x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-011892
- JSON: https://secwatch.observer/filing/0001558370-23-011892.json
- Plain text: https://secwatch.observer/filing/0001558370-23-011892.txt

## Key facts
- Material Agreements
  Dogwood Therapeutics, Inc. entered into Capital On DemandTM Sales Agreement with JonesTrading Institutional Services LLC valued at up to $6.7 million (effective 2023-07-14).
  - Action: entry
  - Agreement: atm program
  - Counterparty: JonesTrading Institutional Services LLC
  - Value: up to $6.7 million
  - Effective: 2023-07-14
  source text: On July 14, 2023, Virios Therapeutics, Inc. (the “Company”) entered into a Capital On DemandTM Sales Agreement (the “Agreement”) with JonesTrading Institutional Services LLC (the “Agent”), pursuant to which the Company may offer and sell, from time to time, through or to the Agent, shares of the Company’s common stock, par value $0.0001 per share, having an aggregate offering price of up to $6.7 million (the “Shares”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818844/000155837023011892/0001558370-23-011892-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.